EFFECT OF ADDING DAPAGLIFLOZIN AS AN ADJUNCT TO INSULIN ON URINARY ALBUMIN-TO-CREATININE RATIO OVER 52 WEEKS IN ADULTS WITH TYPE 1 DIABETESShow others and affiliations
2019 (English)In: Diabetes Technology & Therapeutics, ISSN 1520-9156, E-ISSN 1557-8593, Vol. 21, no Suppl. 1, p. A136-A137Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Mary Ann Liebert, 2019. Vol. 21, no Suppl. 1, p. A136-A137
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:oru:diva-73964DOI: 10.1089/dia.2019.2525.abstractsISI: 000463914000307OAI: oai:DiVA.org:oru-73964DiVA, id: diva2:1307655
Conference
Advanced Technologies & Treatments for Diabetes Conference (ATTD), Berlin, Germany, February 20–23, 2019
2019-04-292019-04-292019-04-29Bibliographically approved